Your browser doesn't support javascript.
Posterior Reversible Encephalopathy Syndrome.
Gewirtz, Alexandra N; Gao, Virginia; Parauda, Sarah C; Robbins, Matthew S.
  • Gewirtz AN; Department of Neurology, New York-Presbyterian Hospital, Weill Cornell Medicine, 525 East 68th Street, New York, NY, 10065, USA. ang9221@nyp.org.
  • Gao V; Department of Neurology, New York-Presbyterian Hospital, Weill Cornell Medicine, 525 East 68th Street, New York, NY, 10065, USA.
  • Parauda SC; Department of Neurology, New York-Presbyterian Hospital, Weill Cornell Medicine, 525 East 68th Street, New York, NY, 10065, USA.
  • Robbins MS; Department of Neurology, New York-Presbyterian Hospital, Weill Cornell Medicine, 525 East 68th Street, New York, NY, 10065, USA.
Curr Pain Headache Rep ; 25(3): 19, 2021 Feb 25.
Article in English | MEDLINE | ID: covidwho-1100995
Semantic information from SemMedBD (by NLM)
1. Headache ASSOCIATED_WITH Posterior reversible encephalopathy syndrome
Subject
Headache
Predicate
ASSOCIATED_WITH
Object
Posterior reversible encephalopathy syndrome
2. COVID-19 PREDISPOSES Posterior reversible encephalopathy syndrome
Subject
COVID-19
Predicate
PREDISPOSES
Object
Posterior reversible encephalopathy syndrome
3. Pandemics OCCURS_IN Patients
Subject
Pandemics
Predicate
OCCURS_IN
Object
Patients
4. Headache ASSOCIATED_WITH Posterior reversible encephalopathy syndrome
Subject
Headache
Predicate
ASSOCIATED_WITH
Object
Posterior reversible encephalopathy syndrome
5. COVID-19 PREDISPOSES Posterior reversible encephalopathy syndrome
Subject
COVID-19
Predicate
PREDISPOSES
Object
Posterior reversible encephalopathy syndrome
6. Pandemics OCCURS_IN Patients
Subject
Pandemics
Predicate
OCCURS_IN
Object
Patients
ABSTRACT
PURPOSE OF REVIEW This review provides an updated discussion on the clinical presentation, diagnosis and radiographic features, mechanisms, associations and epidemiology, treatment, and prognosis of posterior reversible encephalopathy syndrome (PRES). Headache is common in PRES, though headache associated with PRES was not identified as a separate entity in the 2018 International Classification of Headache Disorders. Here, we review the relevant literature and suggest criteria for consideration of its inclusion. RECENT

FINDINGS:

COVID-19 has been identified as a potential risk factor for PRES, with a prevalence of 1-4% in patients with SARS-CoV-2 infection undergoing neuroimaging, thus making a discussion of its identification and treatment particularly timely given the ongoing global pandemic at the time of this writing. PRES is a neuro-clinical syndrome with specific imaging findings. The clinical manifestations of PRES include headache, seizures, encephalopathy, visual disturbances, and focal neurologic deficits. Associations with PRES include renal failure, preeclampsia and eclampsia, autoimmune conditions, and immunosuppression. PRES is theorized to be a syndrome of disordered autoregulation and endothelial dysfunction resulting in preferential hyperperfusion of the posterior circulation. Treatment typically focuses on treating the underlying cause and removal of the offending agents.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Seizures / Vision Disorders / Endothelium / Posterior Leukoencephalopathy Syndrome / Headache Type of study: Prognostic study / Risk factors Limits: Female / Humans / Pregnancy Language: English Journal: Curr Pain Headache Rep Journal subject: Physiology / Neurology / Psychophysiology Year: 2021 Document Type: Article Affiliation country: S11916-020-00932-1

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Seizures / Vision Disorders / Endothelium / Posterior Leukoencephalopathy Syndrome / Headache Type of study: Prognostic study / Risk factors Limits: Female / Humans / Pregnancy Language: English Journal: Curr Pain Headache Rep Journal subject: Physiology / Neurology / Psychophysiology Year: 2021 Document Type: Article Affiliation country: S11916-020-00932-1